Ceryvyn Therapeutics Ltd

0.013

+0.0018.33%

Volume:25.53M

Turnover:321.02K

Market Cap:17.78M

PE:0.05

High:0.013

Open:0.012

Low:0.012

Close:0.012

52wk High:0.600

52wk Low:0.008

Shares:1.37B

Float Shares:786.04M

Volume Ratio:2.09

T/O Rate:3.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.245

EPS(LYR):0.245

ROE:--

ROA:-12.59%

PB:0.60

PE(LYR):0.05

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/CYV.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CYV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CYV.AU\",,,,,undefined,":{"symbol":"CYV.AU","market":"AU","secType":"STK","nameCN":"Ceryvyn Therapeutics Ltd","latestPrice":0.013,"timestamp":1791349920000,"preClose":0.012,"halted":0,"volume":25528533,"delay":0,"changeRate":0.08333333333333326,"nameEN":"Ceryvyn Therapeutics Ltd","floatShares":786037192,"shares":1367978173,"eps":0.2448,"marketStatus":"Not Yet Opened","change":0.001,"latestTime":"10-07 16:12:00 AEDT","open":0.012,"high":0.013,"low":0.012,"amount":321017,"amplitude":0.083333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.2448,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.012,"openAndCloseTimeList":[[1791327600000,1791349200000]],"volumeRatio":2.090746649091762,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CYV.AU","preClose":0.012,"auctionPrice":0.013,"auctionVolume":1869315,"auction":3,"marketStatus":"盘后竞价","timestamp":1791349800344}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CYV.AU\",,,,,undefined,":{"symbol":"CYV.AU","floatShares":786037192,"roa":"-12.59%","roe":"--","lyrEps":0.2448,"volumeRatio":2.090746649091762,"shares":1367978173,"dividePrice":0,"high":0.013,"amplitude":0.083333,"preClose":0.012,"low":0.012,"week52Low":0.008,"pbRate":"0.60","psRate":"17783.72","week52High":0.6,"institutionHeld":0,"latestPrice":0.013,"eps":0.2448,"divideRate":0,"volume":25528533,"delay":0,"ttmEps":0.2448,"open":0.012,"prevYearClose":0.6,"prevWeekClose":0.011,"prevMonthClose":0.01,"prevQuarterClose":0.01,"fiveDayClose":0.01,"twentyDayClose":0.01,"sixtyDayClose":0.014,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYV.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CYV.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663007406","title":"Ceryvyn Therapeutics Posts FY Profit Attributable A$330.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663007406","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663007406?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:37","pubTimestamp":1788172649,"startTime":"0","endTime":"0","summary":"Aug 31 (Reuters) - Ceryvyn Therapeutics Ltd::*FY PROFIT ATTRIBUTABLE A$330.4 MILLION*Further company coverage: CYV.AX* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 31-AUG-202610:19:43.963 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nRSD4DzTnN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CYV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663732550","title":"Ceryvyn Therapeutics - FY Profit Attributable A$330.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663732550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663732550?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:29","pubTimestamp":1788164952,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CYV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650064289","title":"Ceryvyn Therapeutics Ltd-change of Company's Constitution","url":"https://stock-news.laohu8.com/highlight/detail?id=2650064289","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650064289?lang=en_us&edition=fundamental","pubTime":"2026-07-10 11:06","pubTimestamp":1783652782,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nTUE60XF5G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CYV.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CYV.AU\",params:#limit:6,delay:true,,,undefined,":[]}}